Natixis’s Novavax NVAX Stock Holding History

Natixis’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-578	Closed	-$2.77K	–	1158
2023 Q4	$2.77K	Sell	578 -3,547	-86%	-$21.7K	﹤0.01%	975
2023 Q3	$29.9K	Buy	+4,125	New	+$33K	﹤0.01%	848
2022 Q4	–	Sell	-431,553	Closed	-$7.86M	–	1275
2022 Q3	$7.86M	Buy	431,553 +384,280	+813%	+$16.7M	0.04%	309
2022 Q2	$2.43M	Buy	+47,273	New	+$2.45M	0.01%	620
2022 Q1	–	Sell	-2,183	Closed	-$312K	–	1278
2021 Q4	$312K	Buy	+2,183	New	+$375K	﹤0.01%	1126

Other funds holding NVAX

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Natixis's NVAX Position: Q1 2024 in Review

Natixis sold out of Novavax (NVAX) in Q1 2024, closing a stake of 578 shares — an estimated $2.77K sold.

Natixis first reported a position in NVAX in Q4 2021 and held it in 5 quarters. The position peaked at $7.86M in Q3 2022. 201 funds tracked by Wall St. Rank hold NVAX as of Q1 2024.

Natixis reported no remaining Novavax position as of Q1 2024 after selling out during the quarter.
Natixis sold 578 Novavax shares in Q1 2024, an estimated $2.77K.
Natixis first reported a position in Novavax in Q4 2021 and held it in 5 quarters.
Natixis's Novavax position peaked at $7.86M in Q3 2022.
201 funds tracked by Wall St. Rank held Novavax as of Q1 2024.

Based on Natixis's 13F filing for Q1 2024, filed 13 May 2024.